Trichomonas vaginalis: underdiagnosis in urban Australia could facilitate re-emergence

Objectives Trichomonas vaginalis (TV) has a low profile in urban sexually transmitted infection (STI) clinics in many developed countries. The objective of this study was to determine the true prevalence of TV in an Australian urban sexual health setting using sensitive molecular diagnostic techniques. Methods A cross-sectional study investigating the aetiology of cervicitis in women attending two urban sexual health clinics in Sydney, Australia, enrolled 356 consecutive eligible women from 2006 to 2008. The diagnostic yield from the standard clinical practice of discretionary high vaginal wet preparation microscopy in women with suspicious vaginal discharge was compared with universal use of nested PCR for TV of cervical samples. Results TV was detected by PCR in 17/356 women (4.8%, 95% CI 2.8 to 7.5%), whereas only four cases (1.1%, 95% CI 0.3 to 2.8%) were detected by discretionary wet preparation microscopy. Eleven of the 17 women (p=0.003) were of culturally and linguistically diverse background. Additionally, cervicitis was found to be significantly associated with TV, RR 1.66 (1.14 to 2.42), p=0.034. Conclusions Traditional TV-detection methods underestimate TV prevalence in urban Australia. The TV prevalence of 4.8% by PCR testing in this study exceeds previously reported urban Australian TV rates of <1%. An increase in trichomoniasis-associated adverse reproductive outcomes and enhanced HIV transmission poses a salient public health threat. Accordingly, TV warrants a higher profile in urban STI clinic settings in developed countries, and we suggest that priority be given to development of standardised molecular TV detection techniques and that these become part of routine STI testing.

[1]  P. White,et al.  Multiplex PCR Testing Detection of Higher-than-Expected Rates of Cervical Mycoplasma, Ureaplasma, and Trichomonas and Viral Agent Infections in Sexually Active Australian Women , 2009, Journal of Clinical Microbiology.

[2]  J. Hocking,et al.  Temporal Associations With Declining Trichomonas vaginalis Diagnosis Rates Among Women in the State of Victoria, Australia, 1947 to 2005 , 2008, Sexually transmitted diseases.

[3]  P. Konecny,et al.  Cervicitis: a review , 2008, Current opinion in infectious diseases.

[4]  G. Mcquillan,et al.  The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Marrazzo,et al.  Management of women with cervicitis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Baeten,et al.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. , 2007, The Journal of infectious diseases.

[7]  W. Miller,et al.  Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  B. Pol Editorial Commentary: Trichomonas vaginalisInfection: The Most Prevalent Nonviral Sexually Transmitted Infection Receives the Least Public Health Attention , 2007 .

[9]  W. Miller,et al.  A Randomized, Double-Blind, Placebo-Controlled Trial of Combined Nevirapine and Zidovudine Compared with Nevirapine Alone in the Prevention of Perinatal Transmission of HIV in Zimbabwe , 2007 .

[10]  B. Van Der Pol Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  L. Meyn,et al.  The Associations Between Pelvic Inflammatory Disease, Trichomonas vaginalis Infection, and Positive Herpes Simplex Virus Type 2 Serology , 2006, Sexually transmitted diseases.

[12]  B. Van Der Pol,et al.  Use of an Adaptation of a Commercially Available PCR Assay Aimed at Diagnosis of Chlamydia and Gonorrhea To Detect Trichomonas vaginalis in Urogenital Specimens , 2006, Journal of Clinical Microbiology.

[13]  J. Fortenberry,et al.  Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. , 2005, The Journal of infectious diseases.

[14]  J. Hocking,et al.  The incidence of sexually transmitted infections among frequently screened sex workers in a decriminalised and regulated system in Melbourne , 2005, Sexually Transmitted Infections.

[15]  D. Mosure,et al.  Laboratory Tests Used in U.S. Public Health Laboratories for Sexually Transmitted Diseases, 2000 , 2004, Sexually transmitted diseases.

[16]  E. Erbelding,et al.  Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. Schwebke,et al.  Detection of Trichomonosis in Vaginal and Urine Specimens from Women by Culture and PCR , 2000, Journal of Clinical Microbiology.

[18]  G. Garnett,et al.  Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions , 2000, Sexually Transmitted Infections.

[19]  S. Garland,et al.  Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia. , 1999, Sexually transmitted infections.

[20]  M. Krohn,et al.  Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery , 1997, Sexually transmitted diseases.

[21]  O. Jírovec,et al.  Trichomonas vaginalis and trichomoniasis. , 1968, Advances in parasitology.

[22]  R. Trussell,et al.  Triehomonas vaginalis and trichomoniasis. , 1947 .